PHARMA 4.0

 

 

Pharma 4.0, Wednesday 9 December 2020

Panel discussion
09:00

Keynote Panel: Fostering innovation through partnerships

Moderator: Rajendra Srivastava, Dean and Novartis Professor of Marketing Strategy and Innovation, Indian School Of Business
Anand Gautam, Executive Director & Emerging Science Lead, Emerging Science & Innovation (ES&I), Asia & Asia-Pacific (ANZ), Pfizer Worldwide R&D
Vern De Biasi, Vice President, Global Head of Strategic Partnerships, Cyclica Inc.
Melissa Saw, Global Head Of Digital Partnerships, Bayer
Damian O'Connell, Chief Executive Officer Experimental Drug Development Centre, A*STAR
Dr Marinella Sandros
Pharma 4.0
10:00

Accelerating antibody engineering and discovery using synthetic libraries

Dr Marinella Sandros, Senior Global Product Manager, GenScript
Panel discussion
Pharma 4.0
10:30

Panel: Partnering for the future

Moderator: Philip McCloud, Director and Principal Statistician, McCloud Consulting Group Pty Ltd
James Garner, Chief Executive Officer, Kazia Therapeutics Limited
Kevin Lei, Business Development Manager, Atomwise
Sekar Sakthivel, Head, Industry Development, Enterprise Industry Cluster/Singapore Bioimaging Consortium, A*STAR
Charles Stacey
Pharma 4.0
11:30

Neurotech: the next frontier

Charles Stacey, President And Chief Executive Officer, Cerecin
Jeffrey Lu
Pharma 4.0
12:00

Integrating machine learning and combinatorial CRISPR for drug development for the precision medicine paradigm

Jeffrey Lu, Co-Founder And Chief Executive Officer, Engine Biosciences
Pharma 4.0
12:30

Networking break

Pharma 4.0
13:00

Networking break

Aaron Sato
Pharma 4.0
13:30

Synthetic DNA technologies enable antibody discovery and optimization

Aaron Sato, Chief Scientific Officer of Twist Biopharma, Twist Bioscience
Birgit Reitmaier
Pharma 4.0
14:00

Partnerships to accelerate the pipeline

Birgit Reitmaier, Head Of Access To Innovation APAC, Merck Healthcare KGaA
Peter Tobin, Global Medical Director, Merck
Jek Fong
Pharma 4.0
14:30

Personalized Healthcare - Enabling a Next Generation Healthcare Ecosystem to Accelerate Patient Access in Singapore

Jek Fong, Director, Patient Access and Personalised Healthcare, Roche
Ajay Shrivastava
Pharma 4.0
15:00

Using machine learning for effective manufacturing

Ajay Shrivastava, Senior General Manager - Operations, Sun Pharmaceutical Industries Limited
Dean Ho
Pharma 4.0
15:30

CURATE.AI: Finding the optimal drugs and dosage

Dean Ho, Professor and Director, Institute for Digital Medicine (WisDM), National University of Singapore
Khee Suan Bang
Pharma 4.0
16:00

How technology is creating new opportunities for patient centricity

Khee Suan Bang, Manager, Digital Activation Strategy, Danone Nutricia Research
Panel discussion
Pharma 4.0
16:30

Panel: Using digital therapeutics to drive innovation

Moderator: Evelyn Pang, Vice President Marketing, ZP Therapeutics, Zuellig Pharma
Abhishek Shah, Chief Executive Officer, Wellthy Therapeutics
Miguel Rivera, Business Model Transformation Head, Novartis Asia Pacific
Angela Brady, Innovation Research Director, GSK Consumer Health, GSK
Martin-Immanuel Bittner
Pharma 4.0
17:30

Changing paradigms in drug discovery – combining robotics and AI

Martin-Immanuel Bittner, CEO, Arctoris Ltd
last published: 09/Dec/20 03:45
BOOK NOW

 

 

 

DOWNLOAD PROSPECTUS

 

 

For speaking, sponsorship and exhibition opportunities contact jonathan.mottram@terrapinn.com
Tel: +65 6322 2738